BioCentury
ARTICLE | Politics, Policy & Law

Research from Mars can fail patients from Venus

Guest Commentary: Jim Greenwood says industry needs to improve on inclusion of women in clinical trials

October 4, 2018 8:15 PM UTC

Despite rules and directives pushing for clinical trials to include proportional representation of both sexes, some researchers and developers are still behind the curve. FDA, BIO and nonprofit organizations are providing new tools and resources that can help ensure diverse patient populations receive the full benefits of newly commercialized medicines.

Historically, federal dollars flowed to medical research with a disproportionate focus on men’s health...